Skip to main content

Table 2 Compiled statistics of FDA and ANOVA results

From: Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

Gene name

Coordinate axis 1

Coordinate axis 2

p value

Significance

ALG5/EXOSC8

0.815

−0.154

0.001

**

CBX1

0.643

0.079

0.038

*

GRID2

0.655

0.056

0.034

*

GRIN3B

0.627

−0.168

0.039

*

ING3

0.074

0.748

0.020

*

MYO1D

0.666

−0.168

0.023

*

NPHP3-AS1

0.640

−0.186

0.031

*

MSH6/FBXO11

0.366

0.561

0.047

*

SND1

0.187

0.653

0.049

*

SPATS2

0.579

−0.352

0.031

*

TENM4

0.592

0.320

0.032

*

TRA2A

0.563

−0.412

0.025

*

  1. Coordinate axes refer to FDA data values (Fig. 4). P value refers to ANOVA data. *<0.05 **< 0.01
  2. Differentially H3K27me3-enriched genes in prostate cancer tissues compared to normal biopsies
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us